OncoSec Medical
(OTCQB:ONCS)
CEO: Punit Dhillon
[display_podcast]
OncoSec Medical (OTCQB:ONCS) CEO Interview
Newswire
- [ July 22, 2024 ] Richtech Robotics Celebrates Completion of Installation of ADAM at Ghost Kitchens inside Dawsonville, GA Walmart Newsmakers
- [ July 22, 2024 ] MIRA Pharmaceuticals (NASDAQ: MIRA) Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine’s Drug Resistance Newsmakers
- [ July 11, 2024 ] FuelCell (NASDAQ: FCEL) Energy Marks a Significant Milestone in Korean Market Expansion Newsmakers
- [ July 11, 2024 ] Biodexa (NASDAQ: BDRX)Announces Additional Positive Results Of Phase 2 Trial Of eRapa in Treatment Of Precancerous Polyps in the GI Tract – Now 12-Month Data Newsmakers
- [ July 11, 2024 ] Kazia Therapeutics (NASDAQ: KZIA) Announces Phase II/III Clinical Trial Results for Paxalisib in Glioblastoma Newsmakers
- [ July 2, 2024 ] Ocean Power Technologies (NASDAQ: OPTT) Partners with Unique Group for Autonomous Vehicle Services in the Middle East Newsmakers
- [ July 2, 2024 ] Roadzen (NASDAQ: RDZN) Reports Record Revenue Growth in its First Fiscal Year as a Public Company Newsmakers
- [ July 1, 2024 ] Complete Solaria (NASDAQ: CSLR) Eliminates $67.6 Million of Private Equity Debt Newsmakers
- [ July 1, 2024 ] Loop Media (NASDAQ: LPTV) Announces Strategic Partnership with Outpatient Imaging Affiliates to Enhance Patient Experience in Imaging Centers Nationwide Newsmakers
- [ July 1, 2024 ] Senti Bio (NASDAQ: SNTI) Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy Newsmakers
Flash Player 9 or higher is required to view the chart Click here to download Flash Player nowCopyright 1997-2019 Wall Street Reporter / Octagon Media Corp.